Division of Gastroenterology & Hepatology
Leadership
Name:
David Kastenberg, MD
Position:
- Chief, Division of Gastroenterology & Hepatology
- J. Edward Berk Professor of Medicine
Contact
Name:
Division of Gastroenterology & Hepatology
132 South 10th Street
Main Building, Suite 480
Philadelphia, PA 19107
Contact Number(s):
- 215-955-5112
- 215-923-3447 (fax)
Research Activities
Current Clinical Trials
The Division of Gastroenterology & Hepatology conducts a number of clinical trials in various aspects of digestive and liver diseases. For more information on any of these trials, please contact Cynthia Miller, RN, at 215-955-8108.
Learn more about registered studies by visiting clinicaltrials.gov.
Publications
- Comparison of simulated transient elastography sample volumes and global measurements on MRE and MRI-PDFF in patients with suspected MASLD
- Safety and efficacy of same-day discharge after gastric peroral endoscopic myotomy for gastroparesis: a systematic review and meta-analysis
- Utility of repeat colonoscopy attempt after failed colonoscopy: a systematic review and pooled analysis
- Implementation science: a primer for hepatology research
- Establishing standards of practice for transoral outlet reduction: an expert consensus using a modified Delphi method
- Outcomes with Single Tremelimumab Regular Interval Durvalumab (STRIDE) for Unresectable Hepatocellular Carcinoma in the US Veterans Administration
- Artificial intelligence-based prediction of esophageal adenocarcinoma risk in Barrett’s esophagus patients: a literature review
- Transoral outlet reduction for the treatment of dumping syndrome after Roux-en-Y gastric bypass: a systematic review and meta-analysis
- Is this the time to rethink the management options for biliary drainage in patients with malignant hilar biliary obstruction?
- Author Correction: Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study (Nature Medicine, (2026), 32, 1, (197-223), 10.1038/s41591-025-04077-9)
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
- Circulating cell-free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV-positive Nigerian population
- Predicting and Managing Hepatocellular Carcinoma Recurrence After Liver Transplant: A Single-Center Experience 2012–2024
- Deep-learning-based prediction of significant portal hypertension with single cross-sectional non-enhanced CT
- Role of Pre-Endoscopic Metoclopramide in Patients With Acute Upper Gastrointestinal Bleeding: Meta-Analysis of Randomized Controlled Trials
- Beyond the Scope: The Hidden Curriculum in GI Fellowship and Its Implication for Change
- Hepatitis C treatment during pregnancy: time for a practice change
- Response:
- Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
- Bowel preparation quality in patients using glucagon-like peptide-1 agonists: a systematic review and meta-analysis